SLCO1B1 P155T - GET-Evidence

Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.

To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.

Please help improve GET-Evidence by evaluating evidence for this variant!


(See the latest version)


(SLCO1B1 Pro155Thr)

You are viewing an old version of this page that was saved on June 22, 2011 at 11:58pm by Genome Importing Robot.

Short summary


Variant evidence
Computational 2

Variant Effect Predictor (Ensembl ):
Mutation Tasting Prediction: Polymorphism p value: 0.749803; protein features (might be) affected.
SIFT: Affect protein function 0.04
GVGD: GV 73.35; GD 28.88; Class C0
Multi-alignment of Q9Y6L6.2 solute carrier organic anion transporter family member 1B1 [Homo sapiens] with; XP_520785.2 [Pan troglodytes] XP_003265630.1 [Nomascus leucogenys] XP_001097704.1 [Macaca mulatta] XP_003265628.1 [Nomascus leucogenys] AAV53935.1[Macaca fascicularis] NP_001028113.1 [Macaca mulatta] XP_002752143.1 [Callithrix jacchus] XP_001498086.1 [Equus caballus] XP_002926619.1 [Ailuropoda melanoleuca] XP_002712675.1 [Oryctolagus cuniculus]

Functional -
Case/Control -
Familial -
Clinical importance
Severity -
Treatability -
Penetrance -


Insufficiently evaluated pharmacogenetic

(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)

Inheritance pattern


Summary of published research, and additional commentary


Allele frequency

  • A @ chr12:21329813: 13.5% (1451/10732) in EVS
  • A @ chr12:21221079: 11.7% (15/128) in GET-Evidence
  • Frequency shown in summary reports: 13.5% (1451/10732)


Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, CarriƩ A. Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. Pharmacogenomics. 2008 Sep;9(9):1217-27. PubMed PMID: 18781850.



hu04FD18 - CGI sample GS00253-DNA_F01_200_37
het A @ chr12:21329813



hu43860C - CGI sample GS00253-DNA_A01_200_37
het A @ chr12:21329813


hu604D39 - CGI sample GS00253-DNA_B02_200_37
het A @ chr12:21329813



hu9385BA - CGI sample GS00253-DNA_E01_200_37
het A @ chr12:21329813


GS06985 - var-GS06985-1100-36-ASM
het A @ chr12:21221080


GS06994 - var-GS06994-1100-36-ASM
het A @ chr12:21221080


GS10851 - var-GS10851-1100-36-ASM
het A @ chr12:21221080


GS12004 - var-GS12004-1100-36-ASM
hom A @ chr12:21221080


GS19648 - var-GS19648-1100-36-ASM
het A @ chr12:21221080


GS19649 - var-GS19649-1100-36-ASM
het A @ chr12:21221080


GS19701 - var-GS19701-1100-36-ASM
het A @ chr12:21221080


GS20502 - var-GS20502-1100-36-ASM
het A @ chr12:21221080






Deleted in this revision:



Other external references

  • rs11045819
  • [fluvastatin]
    Subjects homozygous for this genotype showed decreased response to fluvastatin

Other in silico analyses

  • NBLOSUM100 score = 4
  • GET-Evidence autoscore = 1

Edit history

Gene search

"GENE" or "GENE A123C":

Log in